User profiles for Stephen J. Thomas
 | Stephen J. Thomas, MDChair of Microbiology & Immunology Verified email at upstate.edu Cited by 28231 |
[HTML][HTML] Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine
…, SJ Thomas, N Kitchin, J Absalon… - New England journal …, 2020 - Mass Medical Soc
Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and
the resulting coronavirus disease 2019 (Covid-19) have afflicted tens of millions of people in …
the resulting coronavirus disease 2019 (Covid-19) have afflicted tens of millions of people in …
Protective efficacy of multiple vaccine platforms against Zika virus challenge in rhesus monkeys
Zika virus (ZIKV) is responsible for a major ongoing epidemic in the Americas and has been
causally associated with fetal microcephaly. The development of a safe and effective ZIKV …
causally associated with fetal microcephaly. The development of a safe and effective ZIKV …
[HTML][HTML] Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine through 6 months
SJ Thomas, ED Moreira Jr, N Kitchin… - … England Journal of …, 2021 - Mass Medical Soc
Background BNT162b2 is a lipid nanoparticle–formulated, nucleoside-modified RNA vaccine
encoding a prefusion-stabilized, membrane-anchored severe acute respiratory syndrome …
encoding a prefusion-stabilized, membrane-anchored severe acute respiratory syndrome …
[HTML][HTML] Vaccine protection against Zika virus from Brazil
Zika virus (ZIKV) is a flavivirus that is responsible for the current epidemic in Brazil and the
Americas 1 , 2 . ZIKV has been causally associated with fetal microcephaly, intrauterine …
Americas 1 , 2 . ZIKV has been causally associated with fetal microcephaly, intrauterine …
Safety and immunogenicity of an anti-Middle East respiratory syndrome coronavirus DNA vaccine: a phase 1, open-label, single-arm, dose-escalation trial
…, NL Michael, DB Weiner, SJ Thomas… - The Lancet Infectious …, 2019 - thelancet.com
Background Middle East respiratory syndrome (MERS) coronavirus causes a highly fatal
lower-respiratory tract infection. There are as yet no licensed MERS vaccines or therapeutics. …
lower-respiratory tract infection. There are as yet no licensed MERS vaccines or therapeutics. …
[HTML][HTML] Safety, immunogenicity, and efficacy of the BNT162b2 Covid-19 vaccine in adolescents
…, T Jennings, DM Brandon, SJ Thomas… - … England Journal of …, 2021 - Mass Medical Soc
Background Until very recently, vaccines against severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2) had not been authorized for emergency use in persons younger than …
2 (SARS-CoV-2) had not been authorized for emergency use in persons younger than …
[HTML][HTML] Thyroid hormone treatment after coronary-artery bypass surgery
…, RE Helm, K Ojamaa, SJ Thomas… - … England Journal of …, 1995 - Mass Medical Soc
Background Thyroid hormone has many effects on the cardiovascular system. During and
after cardiopulmonary bypass, serum triiodothyronine concentrations decline transiently, …
after cardiopulmonary bypass, serum triiodothyronine concentrations decline transiently, …
[HTML][HTML] Improvement of outcomes after coronary artery bypass: a randomized trial comparing intraoperative high versus low mean arterial pressure
…, JP Hollenberg, D Barbut, JG Hayes, SJ Thomas… - The Journal of thoracic …, 1995 - Elsevier
Background The objective of this randomized clinical trial of elective coronary artery bypass
grafting was to investigate whether intraoperative mean arterial pressure below …
grafting was to investigate whether intraoperative mean arterial pressure below …
[HTML][HTML] A recombinant vesicular stomatitis virus Ebola vaccine
…, NL Michael, RT Davey Jr, SJ Thomas - … England Journal of …, 2017 - Mass Medical Soc
Background The worst Ebola virus disease (EVD) outbreak in history has resulted in more
than 28,000 cases and 11,000 deaths. We present the final results of two phase 1 trials of an …
than 28,000 cases and 11,000 deaths. We present the final results of two phase 1 trials of an …
[HTML][HTML] Serotype-specific differences in the risk of dengue hemorrhagic fever: an analysis of data collected in Bangkok, Thailand from 1994 to 2006
…, RV Gibbons, S Kalayanarooj, SJ Thomas… - PLoS neglected …, 2010 - journals.plos.org
Background It is unclear whether dengue serotypes differ in their propensity to cause
severe disease. We analyzed differences in serotype-specific disease severity in children …
severe disease. We analyzed differences in serotype-specific disease severity in children …